CPR Stock Overview
Engages in the manufacture and sale of windows and doors in Europe.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Compremum S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł2.00 |
| 52 Week High | zł2.57 |
| 52 Week Low | zł1.74 |
| Beta | 0.88 |
| 1 Month Change | -2.21% |
| 3 Month Change | 3.91% |
| 1 Year Change | -15.82% |
| 3 Year Change | -41.67% |
| 5 Year Change | -0.25% |
| Change since IPO | -18.90% |
Recent News & Updates
Compremum's (WSE:CPR) Solid Earnings Are Supported By Other Strong Factors
May 08
Compremum (WSE:CPR) Is Looking To Continue Growing Its Returns On Capital
Mar 12Recent updates
Compremum's (WSE:CPR) Solid Earnings Are Supported By Other Strong Factors
May 08Compremum (WSE:CPR) Is Looking To Continue Growing Its Returns On Capital
Mar 12Compremum (WSE:CPR) Is Looking To Continue Growing Its Returns On Capital
May 11Here's Why Compremum (WSE:CPR) Has A Meaningful Debt Burden
Jan 10We Like These Underlying Return On Capital Trends At Compremum (WSE:CPR)
Nov 18Compremum (WSE:CPR) Is Looking To Continue Growing Its Returns On Capital
Aug 05What Does Compremum S.A.'s (WSE:CPR) Share Price Indicate?
Jun 03Do Compremum's (WSE:CPR) Earnings Warrant Your Attention?
Apr 28Here's Why Compremum (WSE:CPR) Can Manage Its Debt Responsibly
Feb 22Is Now The Time To Put Pozbud T&R Spolka Akcyjna (WSE:POZ) On Your Watchlist?
Jan 05We Like These Underlying Return On Capital Trends At Pozbud T&R Spolka Akcyjna (WSE:POZ)
Nov 22Is Pozbud T&R Spolka Akcyjna (WSE:POZ) A Risky Investment?
Oct 05With EPS Growth And More, Pozbud T&R Spolka Akcyjna (WSE:POZ) Is Interesting
Jul 06We Like These Underlying Return On Capital Trends At Pozbud T&R Spolka Akcyjna (WSE:POZ)
Jun 10Pozbud T&R Spolka Akcyjna (WSE:POZ) Seems To Use Debt Quite Sensibly
May 12Do Pozbud T&R Spolka Akcyjna's (WSE:POZ) Earnings Warrant Your Attention?
Mar 11Is Pozbud T&R Spolka Akcyjna (WSE:POZ) Using Too Much Debt?
Feb 04
We're Not So Sure You Should Rely on Pozbud T&R Spolka Akcyjna's (WSE:POZ) Statutory Earnings
Dec 29Does Pozbud T&R Spolka Akcyjna (WSE:POZ) Deserve A Spot On Your Watchlist?
Dec 02Shareholder Returns
| CPR | PL Building | PL Market | |
|---|---|---|---|
| 7D | -0.3% | -3.9% | -2.7% |
| 1Y | -15.8% | 19.1% | 24.5% |
Return vs Industry: CPR underperformed the Polish Building industry which returned 19.1% over the past year.
Return vs Market: CPR underperformed the Polish Market which returned 24.5% over the past year.
Price Volatility
| CPR volatility | |
|---|---|
| CPR Average Weekly Movement | 7.2% |
| Building Industry Average Movement | 6.5% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PL Market | 9.2% |
| 10% least volatile stocks in PL Market | 3.4% |
Stable Share Price: CPR has not had significant price volatility in the past 3 months.
Volatility Over Time: CPR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 93 | n/a | compremum.pl |
Compremum S.A. engages in the manufacture and sale of windows and doors in Europe. The company operates through Joinery, Construction Services, Development Services, Railway Industry, and Renewable Energy Sources segments. It offers windows and doors of wood, wood aluminum and aluminum.
Compremum S.A. Fundamentals Summary
| CPR fundamental statistics | |
|---|---|
| Market cap | zł89.45m |
| Earnings (TTM) | zł17.43m |
| Revenue (TTM) | zł288.69m |
5.1x
P/E Ratio0.3x
P/S RatioIs CPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CPR income statement (TTM) | |
|---|---|
| Revenue | zł288.69m |
| Cost of Revenue | zł238.91m |
| Gross Profit | zł49.78m |
| Other Expenses | zł32.35m |
| Earnings | zł17.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Sep 25, 2024
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 17.24% |
| Net Profit Margin | 6.04% |
| Debt/Equity Ratio | 25.2% |
How did CPR perform over the long term?
See historical performance and comparison